281 related articles for article (PubMed ID: 27780754)
1. PPARγ agonists induce adipocyte differentiation by modulating the expression of Lipin-1, which acts as a PPARγ phosphatase.
Kim J; Lee YJ; Kim JM; Lee SY; Bae MA; Ahn JH; Han DC; Kwon BM
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):57-66. PubMed ID: 27780754
[TBL] [Abstract][Full Text] [Related]
2. Lipin-1 phosphatidic phosphatase activity modulates phosphatidate levels to promote peroxisome proliferator-activated receptor γ (PPARγ) gene expression during adipogenesis.
Zhang P; Takeuchi K; Csaki LS; Reue K
J Biol Chem; 2012 Jan; 287(5):3485-94. PubMed ID: 22157014
[TBL] [Abstract][Full Text] [Related]
3. 6-gingerol inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes.
Tzeng TF; Chang CJ; Liu IM
Phytother Res; 2014 Feb; 28(2):187-92. PubMed ID: 23519881
[TBL] [Abstract][Full Text] [Related]
4. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro.
Phan J; Péterfy M; Reue K
J Biol Chem; 2004 Jul; 279(28):29558-64. PubMed ID: 15123608
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress suppresses lipin-1 expression in 3T3-L1 adipocytes.
Takahashi N; Yoshizaki T; Hiranaka N; Suzuki T; Yui T; Akanuma M; Kanazawa K; Yoshida M; Naito S; Fujiya M; Kohgo Y; Ieko M
Biochem Biophys Res Commun; 2013 Feb; 431(1):25-30. PubMed ID: 23291236
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of the phosphatidate phosphatases lipin 1 and 2 during adipogenesis and lipid droplet biogenesis in 3T3-L1 cells.
Sembongi H; Miranda M; Han GS; Fakas S; Grimsey N; Vendrell J; Carman GM; Siniossoglou S
J Biol Chem; 2013 Nov; 288(48):34502-13. PubMed ID: 24133206
[TBL] [Abstract][Full Text] [Related]
7. PPARγ agonist through the terminal differentiation phase is essential for adipogenic differentiation of fetal ovine preadipocytes.
Pu Y; Veiga-Lopez A
Cell Mol Biol Lett; 2017; 22():6. PubMed ID: 28536637
[TBL] [Abstract][Full Text] [Related]
8. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.
Milton FA; Cvoro A; Amato AA; Sieglaff DH; Filgueira CS; Arumanayagam AS; de Lima Mdo C; Pitta IR; de Assis Rocha Neves F; Webb P
Biochem Biophys Res Commun; 2015 Aug; 464(3):718-23. PubMed ID: 26168725
[TBL] [Abstract][Full Text] [Related]
9. A possible regulatory link between Twist 1 and PPARγ gene regulation in 3T3-L1 adipocytes.
Ren R; Chen Z; Zhao X; Sun T; Zhang Y; Chen J; Lu S; Ma W
Lipids Health Dis; 2016 Nov; 15(1):189. PubMed ID: 27825360
[TBL] [Abstract][Full Text] [Related]
10. C1q/TNF-related protein 3 expression and effects on adipocyte differentiation of 3T3-L1 cells.
Nishimoto H; Yamamoto A; Furukawa S; Wakisaka S; Maeda T
Cell Biol Int; 2017 Feb; 41(2):197-203. PubMed ID: 27590487
[TBL] [Abstract][Full Text] [Related]
11. The DLK gene is a transcriptional target of PPARγ.
Couture JP; Blouin R
Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
[TBL] [Abstract][Full Text] [Related]
12. (+)-Episesamin inhibits adipogenesis and exerts anti-inflammatory effects in 3T3-L1 (pre)adipocytes by sustained Wnt signaling, down-regulation of PPARγ and induction of iNOS.
Freise C; Trowitzsch-Kienast W; Erben U; Seehofer D; Kim KY; Zeitz M; Ruehl M; Somasundaram R
J Nutr Biochem; 2013 Mar; 24(3):550-5. PubMed ID: 22818712
[TBL] [Abstract][Full Text] [Related]
13. Vanadium(IV)-chlorodipicolinate inhibits 3T3-L1 preadipocyte adipogenesis by activating LKB1/AMPK signaling pathway.
Zhang L; Huang Y; Liu F; Zhang F; Ding W
J Inorg Biochem; 2016 Sep; 162():1-8. PubMed ID: 27318173
[TBL] [Abstract][Full Text] [Related]
14. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process.
Madsen L; Petersen RK; Sørensen MB; Jørgensen C; Hallenborg P; Pridal L; Fleckner J; Amri EZ; Krieg P; Furstenberger G; Berge RK; Kristiansen K
Biochem J; 2003 Nov; 375(Pt 3):539-49. PubMed ID: 18320708
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis.
Liu C; Feng T; Zhu N; Liu P; Han X; Chen M; Wang X; Li N; Li Y; Xu Y; Si S
Sci Rep; 2015 Apr; 5():9530. PubMed ID: 25827822
[TBL] [Abstract][Full Text] [Related]
16. Screening of medicinal plants for PPARα and PPARγ activation and evaluation of their effects on glucose uptake and 3T3-L1 adipogenesis.
Yang MH; Avula B; Smillie T; Khan IA; Khan SI
Planta Med; 2013 Aug; 79(12):1084-95. PubMed ID: 23877921
[TBL] [Abstract][Full Text] [Related]
17. The role and possible mechanism of lncRNA U90926 in modulating 3T3-L1 preadipocyte differentiation.
Chen J; Liu Y; Lu S; Yin L; Zong C; Cui S; Qin D; Yang Y; Guan Q; Li X; Wang X
Int J Obes (Lond); 2017 Feb; 41(2):299-308. PubMed ID: 27780975
[TBL] [Abstract][Full Text] [Related]
18. Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists.
Tao H; Hajri T
Biochem Pharmacol; 2011 Dec; 82(12):1950-62. PubMed ID: 21924248
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Kong J; Li YC
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
[TBL] [Abstract][Full Text] [Related]
20. RNA interference of PPARgamma using fiber-modified adenovirus vector efficiently suppresses preadipocyte-to-adipocyte differentiation in 3T3-L1 cells.
Hosono T; Mizuguchi H; Katayama K; Koizumi N; Kawabata K; Yamaguchi T; Nakagawa S; Watanabe Y; Mayumi T; Hayakawa T
Gene; 2005 Mar; 348():157-65. PubMed ID: 15777692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
